Related Experiment Video

Updated: Oct 10, 2026

Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells
10:24

Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells

Published on: May 22, 2026

Management of tuberculosis in children

L M Voss1, ,

  • 1Starship Children's Hospital, Auckland, New Zealand. ssinfect@ahsl.co.nz

Journal of Paediatrics and Child Health
|December 15, 2000
PubMed

Insights

This paper outlines tuberculosis (TB) management guidelines, detailing drug regimens and evidence. It addresses drug-resistant TB, corticosteroids, and directly observed therapy for effective patient care.

Area of Science:

  • Pulmonology and Infectious Diseases
  • Microbiology and Immunology

Background:

  • Tuberculosis (TB) remains a significant global health challenge, necessitating updated management strategies.
  • Effective treatment relies on adherence to recommended drug regimens and understanding disease progression.

Framework:

  • Provides evidence-based guidelines for managing both latent tuberculosis infection and active tuberculosis disease.
  • Details general principles of TB care, including specific drug choices and treatment durations.

Implementation:

  • Discusses the role of adjunctive therapies such as corticosteroids in specific TB cases.
  • Highlights the importance of directly observed therapy (DOT) to improve treatment adherence and outcomes.
  • Outlines strategies for managing patients with challenging drug-resistant tuberculosis (DR-TB).

Implications:

  • Aims to standardize and improve the quality of tuberculosis care worldwide.
  • Offers critical guidance for clinicians managing diverse TB patient populations, including those with drug resistance.
  • Contributes to global efforts to control and eliminate tuberculosis through optimized treatment protocols.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories: